XNYS
WLKP
Market cap741mUSD
Oct 20, Last price
21.05USD
Name
Westlake Chemical Partners LP
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Westlake Chemical Partners LP concentrates on acquiring, developing, and operating facilities dedicated to ethylene production, along with related infrastructure, throughout the United States. These plants primarily function by converting ethane into ethylene. Furthermore, the partnership distributes a range of chemical co-products—such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen—directly to external buyers, conducting these sales through either immediate spot transactions or established contractual agreements. Westlake Chemical Partners GP LLC serves as the entity's general partner. The company was founded in 2014 and its corporate headquarters are located in Houston, Texas.
Key people
President, Chief Executive Officer, Director of Westlake Chemical Partners GP LLC · since 2024
Chief Financial Officer, Executive Vice President, Director · since 2020
Andrew Kenner
Senior Vice President - Olefin Materials and Corporate Procurement · since 2022
Chief Accounting Officer, Vice President of Westlake Chemical Partners GP LLC · since 2024
Executive Vice President, Chief Administrative Officer, General Counsel, Corporate Secretary, Director · since 2022
Executive Chairman of the Board of Westlake Chemical Partners GP LLC · since 2024
Senior Chairman of the Board of Westlake Chemical Partners GP LLC · since 2024
G. Stephen Finley
Independent Director of Westlake Chemical Partners GP LLC · since 2020
Lisa Friel
Independent Director of Westlake Chemical Partners GP LLC · since 2023
Randy Woelfel
Independent Director of Westlake Chemical Partners GP LLC · since 2019
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
1209 ORANGE ST
WILMINGTON, DE 19801
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||